Campbell Capital Management’s Pfizer PFE Stock Holding History

Campbell Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-126,857	Closed	-$7.49M	–	51
2021 Q4	$7.49M	Buy	126,857 +5,000	+4%	+$248K	3.09%	9
2021 Q3	$5.24M	Sell	121,857 -1,550	-1%	-$68.7K	2.3%	18
2021 Q2	$4.83M	Sell	123,407 -500	-0.4%	-$19.4K	2.18%	17
2021 Q1	$4.49M	Sell	123,907 -3,373	-3%	-$120K	2.07%	20
2020 Q4	$4.73M	Sell	127,280 -9,982	-7%	-$366K	2.32%	17
2020 Q3	$4.78M	Buy	+137,262	New	+$4.81M	2.74%	15

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Campbell Capital Management's PFE Position: Q1 2022 in Review

Campbell Capital Management sold out of Pfizer (PFE) in Q1 2022, closing a stake of 126,857 shares — an estimated $7.49M sold.

Campbell Capital Management first reported a position in PFE in Q3 2020 and held it in 6 quarters. The position peaked at $7.49M in Q4 2021. 3,195 funds tracked by Wall St. Rank hold PFE as of Q1 2022.

Campbell Capital Management reported no remaining Pfizer position as of Q1 2022 after selling out during the quarter.
Campbell Capital Management sold 126,857 Pfizer shares in Q1 2022, an estimated $7.49M.
Campbell Capital Management first reported a position in Pfizer in Q3 2020 and held it in 6 quarters.
Campbell Capital Management's Pfizer position peaked at $7.49M in Q4 2021.
3,195 funds tracked by Wall St. Rank held Pfizer as of Q1 2022.

Based on Campbell Capital Management's 13F filing for Q1 2022, filed 11 Apr 2022.